Periodic Reporting for period 1 - TWINNIBS (Twinning for excellence in non-invasive brain stimulation in Western Balkans)
Berichtszeitraum: 2022-09-01 bis 2023-11-30
- TWINNIBS will enable the IMR, as the leading biomedical research institute in Serbia, to make organizational changes by transforming one of its most successful research groups into a NIBS dedicated Centre oriented at European standards
- TWINNIBS will enable the IMR to establish a modern R&I Management Unit to support its further growth, scientific profiling, and international reputation.
- The impact of the structural changes will be amplified by introducing new methods and equipment and through engaging in skills and knowledge transfer activities to increase the science and innovation capacities of IMR and collaborating partners
- TWINNIBS will strengthen ties between some of Europe’s frontrunners in the field of NIBS and neuroscience in general and bring them together to jointly tackle some of the key challenges in the field.
- Finally, TWINNIBS will position IMR as a prospective leading partner in international R&I consortia that is able to attract strategic investments and further R&I funding. In terms of wider impact, in the longer term, the project will benefit not only the R&I sector in Serbia but will also bring benefits to the wider EU R&I space.
In addition to these TWINNIBS specified concrete actions to bring substantial scientific, economic/technological, societal, and organizational impact.